share_log
Moomoo 24/7 ·  Apr 2 15:30
Beam Therapeutics Shares Are Trading Lower After Verve Therapeutics Paused Enrollment in Its Heart-1 Clinical Trial. Verve and Beam Previously Entered a License Agreement for Access to Beam's Base Editing, Gene Editing, and Delivery Technologies
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment